Lung cancer risks from plutonium: An updated analysis of data from the Mayak worker cohort

Radiation Research

Volumn 179, Issue 3, 2013, Pages 332-342

  Gilbert, E S ^a   Sokolnikov, M E ^b   Preston, D L ^c   Schonfeld, S J ^a   Schadilov, A E ^b   Vasilenko, E K ^b   Koshurnikova, N A ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Southern Urals Biophysics Institute   (Russian Federation)

^c Hirosoft International Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLUTONIUM;

ADULT; ARTICLE; ATOMIC BOMB SURVIVOR; AUTOPSY; CANCER MORTALITY; CANCER RISK; CARCINOGENIC ACTIVITY; DOSIMETRY; ENVIRONMENTAL EXPOSURE; FEMALE; FOLLOW UP; HUMAN; INDUSTRIAL WORKER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; RADIATION DOSE; RISK ASSESSMENT; RISK FACTOR; RUSSIAN FEDERATION; SMOKING;

ADOLESCENT; ADULT; CARCINOGENS; COHORT STUDIES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASMS, RADIATION-INDUCED; OCCUPATIONAL EXPOSURE; PLUTONIUM; RISK FACTORS; RUSSIA; SMOKING; YOUNG ADULT;

EID: 84874889425     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR3054.1     Document Type: Article

References (21)

1. Sokolnikov ME, Gilbert ES, Preston DL, Ron E, Shilnikova NS, Khokhryakov VV, et al. Lung, liver and bone cancer mortality in Mayak workers. Int J Cancer 2008; 123(4):905-11.
2. Koshurnikova NA, Shilnikova NS, Okatenko PV, Kreslov VV, Bolotnikova MG, Sokolnikov ME, et al. Characteristics of the cohort of workers at the Mayak nuclear complex. Radiat Res 1999; 152(4):352-63.
3. Shilnikova NS, Preston DL, Ron E, Gilbert ES, Vassilenko EK, Romanov SA, et al. Cancer mortality risk among workers at the Mayak nuclear complex. Radiat Res 2003; 159(6):787-98.
4. Vasilenko EK, Khokhryakov VF, Miller SC, Fix JJ, Eckerman K, Choe DO, et al. Mayak worker dosimetry study: An overview. Health Phys 2007; 93(3):190-206.
5. Gilbert ES, Koshurnikova NA, Sokolnikov ME, Shilnikova NS, Preston DL, Ron E, et al. Lung cancer in Mayak workers. Radiat Res 2004; 162(5):505-16.
6. Preston DL, Lubin JL, Pierce, DA, McConney ME. Epicure User's guide. Hirosoft International Corporation: Seattle, WA; 1993.
7. Tomasek L, Rogel A, Tirmarche M, Mitton N, Laurier D. Lung cancer in French and Czech uranium miners: Radon-Associated risk at low exposure rates and modifying effects of time since exposure and age at exposure. Radiat Res 2008; 169(2):125-37.
8. Preston DL, Ron E, Tokuoka S, Funamoto S, Nishi N, Soda M, et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res 2007; 168(1):1-64.
9. Preston DL, Pierce DA, Shimizu Y, Cullings HM, Fujita S, Funamoto S, et al. Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates. Radiat Res 2004; 162(4):377-89.
10. International Commission on Radiological Protection (ICRP). Relative Biological Effectiveness (RBE), Quality Factor (Q) and Radiation Weighting Factors (wR). Oxford: Pergamon Press (ICRP no. 92); 2003. P. 80.
11. Jacob P, Meckbach R, Sokolnikov M, Khokhryakov VV, Vasilenko E. Lung cancer risk of Mayak workers: Modelling of carcinogenesis and bystander effect. Radiat Environ Biophys 2007; 46:383-94.
12. Tokarskaya ZB, Scott BR, Zhuntova GV, Okladnikova ND, Belyaeva ZD, Khokhryakov VF, et al. Interaction of radiation and smoking in lung cancer induction among workers at the Mayak nuclear enterprise. Health Phys 2002; 83(6):833-46.
13. Kreisheimer M, Sokolnikov ME, Koshurnikova NA, Khokhryakov VF, Romanow SA, Shilnikova NS, et al. Lung cancer mortality among nuclear workers of the Mayak facilities in the former Soviet Union. An updated analysis considering smoking as the main confounding factor. Radiat Environ Biophys 2003; 42(2):129-35.
14. National Research Council, Committee on the Biological Effects of Radiation, Health Effects of Exposure to Indoor Radon (BEIR VI). National Academy Press: Washington, D.C.; 1999. P. 500.
15. Furukawa K, Preston DL, Lonn S, Funamoto S, Yonehara S, Matsuo T, et al. Radiation and smoking effects on lung cancer incidence among atomic bomb survivors. Radiat Res 2010; 174(1): 72-82.
16. Omar RZ, Barber JA, Smith PG. Cancer mortality and morbidity among plutonium workers at the Sellafield plant of British Nuclear Fuels. Br J Cancer 1999; 79(7-8):1288-301.
17. Voelz GL, Lawrence JN, Johnson ER. Fifty years of plutonium exposure to the Manhattan Project plutonium workers: An update. Health Phys 1997; 73(4):611-9.
18. Wiggs LD, Johnson ER, Cox-DeVore CA, Voelz GL. Mortality through 1990 among white male workers at the Los Alamos National Laboratory: Considering exposures to plutonium and external ionizing radiation. Health Phys 1994; 67(6):577-88.
19. Brown SC, Schonbeck MF, McClure D, Baron AE, Navidi WC, Byers T, et al. Lung cancer and internal lung doses among plutonium workers at the Rocky Flats Plant: A case-control study. Am J Epidemiol 2004; 160(2):163-72.
20. Krahenbuhl MP, Bess JB, Wilde JL, Vostrotin VV, Suslova KG, Khokhryakov VF, et al. Uncertainty analysis of doses resulting from chronic inhalation of plutonium at the Mayak Production Association. Health Phys 2005; 89(1):33-45.
21. Lubin JH, Boice Jr. JD, Edling C, Hornung RW, Howe GR, Kunz E, et al. Lung cancer in radon-exposed miners and estimation of risk from indoor exposure. J Nat Cancer Inst 1995; 87(11):817-27.